FAKTOR OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Deutsche Boerse AG 20:50:27 27/06/2024 BST | ||
| 2.2 EUR | +18.92% |
|
| Current month | +73.23% | ||
| 1 month | +46.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 2.2 | +18.92% |
| 26/06/24 | 1.85 | +5.11% |
| 25/06/24 | 1.76 | +2.92% |
| 24/06/24 | 1.71 | -1.72% |
| 21/06/24 | 1.74 | +10.83% |
Delayed Quote Deutsche Boerse AG
Last update June 27, 2024 at 08:50 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PG8EWL |
| ISIN | DE000PG8EWL0 |
| Date issued | 02/11/2022 |
| Strike | 91.56 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 73.37 € |
|---|---|
| Lowest since issue | 0.35 € |
| Spread | 0.04 € |
| Spread % | 1.81% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
93.34
USD
Average target price
96.05
USD
Spread / Average Target
+2.91%
- Stock Market
- Certificates
- Certificat
